BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19294598)

  • 1. Serial MR imaging and 1H-MR spectroscopy in monozygotic twins with Tay-Sachs disease.
    Imamura A; Miyajima H; Ito R; Orii KO
    Neuropediatrics; 2008 Oct; 39(5):259-63. PubMed ID: 19294598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
    Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
    Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subacute sclerosing panencephalitis with fulminating course: follow-up magnetic resonance spectroscopy (MRS) findings.
    Alkan A; Kutlu R; Sigirci A; Aslan M; Sarac K; Yakinci C
    J Child Neurol; 2004 Mar; 19(3):233-8. PubMed ID: 15119488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
    Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
    Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging findings in hyperargininemia.
    Güngör S; Akinci A; Firat AK; Tabel Y; Alkan A
    J Neuroimaging; 2008 Oct; 18(4):457-62. PubMed ID: 18321250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton MR spectroscopic findings in paroxysmal kinesigenic dyskinesia.
    Kim MO; Im JH; Choi CG; Lee MC
    Mov Disord; 1998 May; 13(3):570-5. PubMed ID: 9613757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton MR spectroscopy reveals lactate in infantile neuroaxonal dystrophy (INAD).
    Mader I; Krägeloh-Mann I; Seeger U; Bornemann A; Nägele T; Küker W; Grodd W
    Neuropediatrics; 2001 Apr; 32(2):97-100. PubMed ID: 11414651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
    Port JD; Unal SS; Mrazek DA; Marcus SM
    Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
    Villanueva V; Alvarez-Linera J; Gómez-Garre P; Gutiérrez J; Serratosa JM
    Epilepsia; 2006 Apr; 47(4):788-92. PubMed ID: 16650146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain magnetic resonance spectroscopy in Tourette's disorder.
    DeVito TJ; Drost DJ; Pavlosky W; Neufeld RW; Rajakumar N; McKinlay BD; Williamson PC; Nicolson R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1301-8. PubMed ID: 16292123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebral metabolic disturbance in hypoxic encephalopathy: evaluation with H-1 MR spectroscopy].
    Suzuki S; Ichijo M; Fujii H; Ikeda K; Hitosugi M
    Rinsho Shinkeigaku; 1996 Jul; 36(7):844-9. PubMed ID: 8952350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging and 1H-MR spectroscopy in a case of cerebral infarction with transient cerebral arteriopathy.
    Imamura A; Matsuo N; Ariki M; Horikoshi H; Hattori T
    Brain Dev; 2004 Dec; 26(8):535-8. PubMed ID: 15533656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential long-term effects of MDMA on the basal ganglia-thalamocortical circuit: a proton MR spectroscopy and diffusion-tensor imaging study.
    Liu HS; Chou MC; Chung HW; Cho NY; Chiang SW; Wang CY; Kao HW; Huang GS; Chen CY
    Radiology; 2011 Aug; 260(2):531-40. PubMed ID: 21633053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Zacharia TT; Law M; Naidich TP; Leeds NE
    J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio.
    Okada T; Sakamoto S; Nakamoto Y; Kohara N; Senda M
    Psychiatry Res; 2007 Nov; 156(2):169-74. PubMed ID: 17900878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral 1H MR spectroscopy revealing white matter NAA decreases in glutaric aciduria type I.
    Sijens PE; Smit GP; Meiners LC; Oudkerk M; van Spronsen FJ
    Mol Genet Metab; 2006 Jul; 88(3):285-9. PubMed ID: 16488172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.